Gene expression microarray studies demonstrated that about 30% of the luminal B tumors are ER+ and/or PR+/HER-2+; whereas 70% of the luminal B carcinomas have the same ER+ and/or PR+, HER-2− profile as luminal A tumors in African American [3]. Here, ERBB2 is linked to carcinoma.